Woodford reveals his full portfolio
Neil Woodford recently revealed the top ten holdings in the new Woodford Equity Income fund. Now he’s gone one step further and announced the holdings in full.
Star fund manager Neil Woodford recently revealed the top ten holdings in the new Woodford Equity Income fund.
Now he's gone one step further and announced the holdings in full on his fund website. Woodford intends that this will be updated every month.
It will come as no surprise that large-cap pharmaceutical stocks are among the favourites. AstraZeneca and GSK are the top two holdings, at 8.3% and 7.1% of the fund respectively. Other big firms from the sector include Roche, Sanofi, Novartis, and Prothena which together make up 9.9% of the portfolio.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
As my colleague Ed Bowsher remarked earlier today, Woodford is a big fan of tobacco stocks (not a view that Ed shares).In fact, tobacco makes up over 18% of the portfolio.
He's also keen on government outsourcers, with G4S, Serco and Capita making up 4.96%, and on traditional utilities - Drax, SSE, and Centrica come in at 4.9% of the portfolio.
Further down the list come quite a few small-cap pharmaceutical and biotech stocks, including ReNeuron, Retroscreen Virology, e-Therapeutics, Oxford Pharmascience, and 4D Pharma.
Biotech is a hot topic at the moment, and my colleague Matthew Partridge recently picked a couple of interesting small-cap biotech stocks that are looking in to the new generation of antibiotics.
And earlier this year in MoneyWeek magazine, he looked at the opportunities available to investors in stem-cell research.If you're not already a subscriber, get your first four copies free here.
Here's the full list of the stocks in the Woodford Equity Income Fund.
1 | AstraZeneca | Healthcare | 8.3% |
2 | GlaxoSmithKline | Healthcare | 7.1% |
3 | British American Tobacco | Consumer goods | 6.2% |
4 | BT | Telecommunications | 6% |
5 | Imperial Tobacco | Consumer goods | 5.3% |
6 | Roche | Healthcare | 3.9% |
7 | Imperial Innovations | Financials | 3.6% |
8 | Reynolds American | Consumer goods | 3.6% |
9 | Rolls-Royce | Industrials | 3.5% |
10 | Capita | Industrials | 3.4% |
11 | Allied Minds | Financials | 2.9% |
12 | BAe Systems | Industrials | 2.9% |
13 | HSBC | Financials | 2.8% |
14 | Sanofi | Healthcare | 2.3% |
15 | Legal & General | Financials | 2.1% |
16 | Novartis | Healthcare | 2% |
17 | Centrica | Utilities | 2% |
18 | AA | Consumer services | 1.9% |
19 | SSE | Utilities | 1.8% |
20 | Reckitt Benckiser | Consumer goods | 1.8% |
21 | Philip Morris International | Consumer goods | 1.8% |
22 | Prothena | Healthcare | 1.7% |
23 | Next | Consumer services | 1.7% |
24 | Altria | Consumer goods | 1.3% |
25 | Smith & Nephew | Healthcare | 1.3% |
26 | BTG | Healthcare | 1.2% |
27 | Provident Financial | Financials | 1.1% |
28 | Drax | Utilities | 1.1% |
29 | Alkermes | Healthcare | 1% |
30 | Gagfah | Financials | 1% |
31 | G4S | Industrials | 0.97% |
32 | RM2 International | Industrials | 0.93% |
33 | Redde | Financials | 0.90% |
34 | Utilitywise | Industrials | 0.62% |
35 | Serco | Industrials | 0.59% |
36 | Meggitt | Industrials | 0.59% |
37 | Lancashire | Financials | 0.58% |
38 | Velocys | Oil & gas | 0.55% |
39 | e-Therapeutics | Healthcare | 0.54% |
40 | Vernalis | Healthcare | 0.49% |
41 | ReNeuron | Healthcare | 0.48% |
42 | Cobham | Industrials | 0.48% |
43 | Burford Capital | Financials | 0.44% |
44 | Catlin | Financials | 0.43% |
45 | Benchmark | Healthcare | 0.43% |
46 | Amlin | Financials | 0.43% |
47 | 4D Pharma | Healthcare | 0.43% |
48 | Oxford Pharmascience | Healthcare | 0.35% |
49 | Revolymer | Basic materials | 0.31% |
50 | Hiscox | Financials | 0.31% |
51 | Beazley | Financials | 0.29% |
52 | Gigaclear | Telecommunications | 0.29% |
53 | Paypoint | Industrials | 0.25% |
54 | Homeserve | Industrials | 0.09% |
55 | Retroscreen Virology | Healthcare | 0.09% |
56 | Xeros | Industrials | 0.07% |
57 | NetScientific | Healthcare | 0.05% |
58 | IP | Financials | 0.04% |
59 | Circassia | Healthcare | 0.03% |
60 | Stobart | Industrials | 0.03% |
61 | Cranswick | Consumer goods | 0.01% |
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Ben studied modern languages at London University's Queen Mary College. After dabbling unhappily in local government finance for a while, he went to work for The Scotsman newspaper in Edinburgh. The launch of the paper's website, scotsman.com, in the early years of the dotcom craze, saw Ben move online to manage the Business and Motors channels before becoming deputy editor with responsibility for all aspects of online production for The Scotsman, Scotland on Sunday and the Edinburgh Evening News websites, along with the papers' Edinburgh Festivals website.
Ben joined MoneyWeek as website editor in 2008, just as the Great Financial Crisis was brewing. He has written extensively for the website and magazine, with a particular emphasis on alternative finance and fintech, including blockchain and bitcoin.
As an early adopter of bitcoin, Ben bought when the price was under $200, but went on to spend it all on foolish fripperies.
-
Ocado shares jump 14% after sales surge
The rise in sales comes after Ocado was dumped out of the FTSE 100 in June
By Chris Newlands Published
-
Cash ISA subscriptions surge - but will the chancellor cap ISA benefits in the Budget?
The number of savers using cash ISAs has jumped by 11%, while the popularity of stocks and shares ISAs has declined. Could ISAs be a target in the Autumn Budget?
By Ruth Emery Published